Valganciclovir is converted to ganciclovir, which HSV-1 thymidine kinase phosphorylates; the resulting triphosphate is incorporated into DNA, inhibiting DNA polymerase and DNA synthesis, killing the HSV-TK–expressing cells (with a bystander effect).